Parallax Volatility Advisers’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,504
| Closed | -$13.1K | – | 1222 |
|
|
2023
Q1 | $13.1K | Hold |
3,504
| – | – | ﹤0.01% | 673 |
|
|
2022
Q4 | $10.8K | Sell |
3,504
-166
| -5% | -$513 | ﹤0.01% | 720 |
|
|
2022
Q3 | $17K | Buy |
3,670
+1,235
| +51% | +$5.72K | ﹤0.01% | 844 |
|
|
2022
Q2 | $64K | Sell |
2,435
-393
| -14% | -$10.3K | ﹤0.01% | 759 |
|
|
2022
Q1 | $105K | Sell |
2,828
-337
| -11% | -$12.5K | ﹤0.01% | 734 |
|
|
2021
Q4 | $185K | Buy |
3,165
+1,684
| +114% | +$98.4K | ﹤0.01% | 504 |
|
|
2021
Q3 | $122K | Hold |
1,481
| – | – | ﹤0.01% | 540 |
|
|
2021
Q2 | $140K | Hold |
1,481
| – | – | ﹤0.01% | 377 |
|
|
2021
Q1 | $95K | Hold |
1,481
| – | – | ﹤0.01% | 416 |
|
|
2020
Q4 | $86K | Hold |
1,481
| – | – | ﹤0.01% | 740 |
|
|
2020
Q3 | $31K | Hold |
1,481
| – | – | ﹤0.01% | 1119 |
|
|
2020
Q2 | $23K | Hold |
1,481
| – | – | ﹤0.01% | 923 |
|
|
2020
Q1 | $20K | Hold |
1,481
| – | – | ﹤0.01% | 888 |
|
|
2019
Q4 | $31K | Hold |
1,481
| – | – | ﹤0.01% | 833 |
|
|
2019
Q3 | $48K | Hold |
1,481
| – | – | ﹤0.01% | 742 |
|
|
2019
Q2 | $32K | Hold |
1,481
| – | – | ﹤0.01% | 712 |
|
|
2019
Q1 | $57K | Hold |
1,481
| – | – | ﹤0.01% | 918 |
|
|
2018
Q4 | $67K | Hold |
1,481
| – | – | ﹤0.01% | 797 |
|
|
2018
Q3 | $64K | Hold |
1,481
| – | – | ﹤0.01% | 563 |
|
|
2018
Q2 | $61K | Hold |
1,481
| – | – | ﹤0.01% | 509 |
|
|
2018
Q1 | $41K | Hold |
1,481
| – | – | ﹤0.01% | 706 |
|
|
2017
Q4 | $49K | Sell |
1,481
-7,714
| -84% | -$255K | ﹤0.01% | 2115 |
|
|
2017
Q3 | $441K | Hold |
9,195
| – | – | ﹤0.01% | 299 |
|
|
2017
Q2 | $516K | Hold |
9,195
| – | – | ﹤0.01% | 278 |
|
|
2017
Q1 | $541K | Sell |
9,195
-253
| -3% | -$14.9K | ﹤0.01% | 271 |
|
|
2016
Q4 | $1.06M | Sell |
9,448
-285
| -3% | -$31.9K | ﹤0.01% | 221 |
|
|
2016
Q3 | $1.24M | Sell |
9,733
-70
| -0.7% | -$8.88K | ﹤0.01% | 229 |
|
|
2016
Q2 | $1.15M | Buy |
+9,803
| New | +$1.15M | ﹤0.01% | 205 |
|